Kombinirano liječenje senilne neovaskularne makularne degeneracije primjenom bevacizumaba i fotodinamske terapije : doktorski rad
Introduction: Age-Related Macular Degeneration is a leading cause of severe visual loss in
population over 50 in Western countries with neovascular subtype accounting for the most of
severe cases. Available treatment modalities including Vascular Endothelial Growth Factor
inhibitors (antiVEGF) and verteporfin photodynamic therapy (PDT) are of limited efficiency
and require prolonged treatment.…
Myötävaikuttajat
- Gabrić, Nikica
Luoja
- Lazić, Ratimir
Julkaisija
- University of Rijeka. Faculty of Medicine.
Aihe
- BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences.
- Surgery. Orthopaedics. Ophthalmology
- AMD
- bevacizumab
- PDT
- verteporfin
- antiVEGF
Aineisto tyyppi
- info:eu-repo/semantics/doctoralThesis
- text
Päivämäärä
- 2010-12-23
- 2010-12-23
Myötävaikuttajat
- Gabrić, Nikica
Luoja
- Lazić, Ratimir
Julkaisija
- University of Rijeka. Faculty of Medicine.
Aihe
- BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences.
- Surgery. Orthopaedics. Ophthalmology
- AMD
- bevacizumab
- PDT
- verteporfin
- antiVEGF
Aineisto tyyppi
- info:eu-repo/semantics/doctoralThesis
- text
Päivämäärä
- 2010-12-23
- 2010-12-23
Aineiston tarjoaja
Aggregaattori
Tämän aineisto median lisenssi (ellei toisin mainita)
- http://rightsstatements.org/vocab/InC/1.0/
Tunniste
- https://dr.nsk.hr/islandora/object/svkri:3122
- https://urn.nsk.hr/urn:nbn:hr:188:892351
- https://www.unirepository.svkri.uniri.hr/islandora/object/svkri:3122
- https://dr.nsk.hr/islandora/object/svkri%3A3122/datastream/TN/view/
Muoto
- application/pdf
Kieli
- hrv
Alkuperämaa
- Croatia
Kokoelman nimi
Julkaistu ensimmäistä kertaa Europeana
- 2019-04-05T13:44:36.130Z
Viimeksi päivitetty aineiston tarjoajalta
- 2019-04-05T13:44:36.130Z